Review began 01/06/2023 review ended 01/21/2023 published 01/25/2023 © copyright

HIGHLIGHTS

• who: Report and colleagues from the (UNIVERSITY) have published the Article: Review began 01/06/2023 Review ended 01/21/2023 Published 01/25/2023 u00a9 Copyright, in the Journal: (JOURNAL) of January/25,/2023
• what: The authors aim to emphasize the benefits of HFNC as an add-on therapy for the management of chronic breathlessness since the patient experienced an improvement in breathing and exercise tolerance. The authors report the case of an adolescent with a severe PCD phenotype associated with a rare genotype.
• future: Studies are needed to achieve optimal and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.